Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Ultrasound (Leeds, England)|July 20, 2016
Malignant focal liver lesions at contrast-enhanced ultrasonography and magnetic resonance with hepatospecific contrast agentM D'Onofrio, S Crosara, R De Robertis, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|October 2, 2012
Comparison between CT and CEUS in the diagnosis of pancreatic adenocarcinomaM D'Onofrio, S Crosara, M Signorini, et al.
La Radiologia Medica|September 17, 2009
Contrast-enhanced ultrasonography (CEUS) immediately after percutaneous ablation of hepatocellular carcinomaA Gallotti, M D'Onofrio, A Ruzzenente, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|June 14, 2021
Low torcular Herophili position and large brainstem-tentorium angle in fetuses with open spinal dysraphism at 11-13 weeks' gestationP Volpe, R De Robertis, T Fanelli, et al.
Journal of Imaging Informatics in Medicine|August 5, 2025
Can Machine Learning Predict Metastatic Sites in Pancreatic Ductal Adenocarcinoma? A Radiomic AnalysisF Spoto, R De Robertis, N Cardobi, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|September 17, 2014
Diagnostic performance of contrast-enhanced ultrasound (CEUS) and contrast-enhanced endoscopic ultrasound (ECEUS) for the differentiation of pancreatic lesions: a systematic review and meta-analysisM D'Onofrio, E Biagioli, C Gerardi, et al.
The British Journal of Surgery|August 15, 2018
Importance of main pancreatic duct dilatation in IPMN undergoing surveillanceG Marchegiani, S Andrianello, G Morbin, et al.
Journal of Neuroendocrinology|August 18, 2025
Intraoperative hepatic ultrasonography in patients with gastrointestinal and pancreatic neuroendocrine neoplasms without preoperative evidence of liver metastasesL Viganò, M Maruccio, F Faustini, et al.
ESMO Open|November 12, 2025
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)F Spada, F Gelsomino, M Rinzivillo, et al.
Pageof 1